Diet Effects in Gut Microbiome and Obesity

Journal of Food Science

Volumn 79, Issue 4, 2014, Pages

  Chen, Jia ^a   He, Xianzhi ^a   Huang, Jinhai ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Diet; Gut microbiota; Obesity; Prebiotic

Indexed keywords

BACTERIA (MICROORGANISMS);

PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIUM; DIET; FERMENTATION; HUMAN; IMMUNE SYSTEM; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; OBESITY;

BACTERIA; DIET; FERMENTATION; HUMANS; IMMUNE SYSTEM; INTESTINES; MICROBIOTA; OBESITY; PREBIOTICS; PROBIOTICS;

EID: 84897996520     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.12397     Document Type: Article

References (149)

1. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. 2013. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. (in press), doi: 10.1111/cea.12253.
2. Adlerberth I, Wold AE. 2009. Establishment of the gut microbiota in Western infants. Acta Paediatr 98(2):229-38.
3. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferriéres J. 2008. Energy intake is associated with endotoxemia in apparently healthy men. Amer J Clin Nutr 87(5):1219-23.
4. Anadón A, Rosa Martínez-Larrañaga M, Aranzazu Martínez M. 2006. Probiotics for animal nutrition in the European Union: regulation and safety assessment. Regul Toxicol Pharmacol 45(1):91-5.
5. Angelakis E, Raoult D. 2010. The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain. PLoS One 5(5):e10463.
6. Angelakis E, Bastelica D, Ben Amara A, El Filali A, Dutour A, Mege J-L, Alessi M-C, Raoult D. 2012. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microb Pathog 52(1):61-8.
7. Aronsson L, Huang Y, Parini P, Korach-André M, Håkansson J, Gustafsson J-Å, Pettersson S, Arulampalam V, Rafter J. 2010. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5(9):e13087.
8. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci 104(3):979-84.
9. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Sci Signal 101(44):15718-23.
10. Basseri RJ, Basseri B, Pimentel M, Chong K, Youdim A, Low K, Hwang L, Soffer E, Chang C, Mathur R. 2012. Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterol Hepatol 8(1):22-8.
11. Beards E, Tuohy K, Gibson G. 2010. Bacterial, SCFA and gas profiles of a range of food ingredients following in vitro fermentation by human colonic microbiota. Anaerobe 16(4):420-5.
12. Beaugerie L, Petit J-C. 2004. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best practice research. Clin Gastroenterol 18(2):337-52.
13. Benson AK, Kelly SA, Legge R, Ma F, Low SJ, Kim J, Zhang M, Oh PL, Nehrenberg D, Hua K. 2010. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci 107(44):18933-8.
14. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C. 2010. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5(5):e10667.
15. Bisgaard H, Li N, Bonnelykke K, Chawes BLK, Skov T, Paludan-Müller G, Stokholm J, Smith B, Krogfelt KA. 2011. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin Immunol 128(3):646-52. e5.
16. Bjursell M, Admyre T, Göransson M, Marley AE, Smith DM, Oscarsson J, Bohlooly YM. 2011. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol-Endocrinol Metab 300(1):E211-20.
17. Brignardello J, Morales P, Diaz E, Romero J, Brunser O, Gotteland M. 2010. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther 32(11-12):1307-14.
18. Brinkworth GD, Noakes M, Clifton PM, Bird AR. 2009. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 101(10):1493-502.
19. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ. 2003. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278(13):11312-9.
20. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palù G, Martines D. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Amer J Physiol - Gastrointestinal Liver Physiol 292(2):G518-25.
21. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761-72.
22. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470-81.
23. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM. 2009a. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Amer J Clin Nutr 90(5):1236-43.
24. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM. 2009b. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091-103.
25. Cani PD, Neyrinck AM, Maton N, Delzenne NM. 2012. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes. Res. 13(6):1000-7.
26. Connolly ML, Lovegrove JA, Tuohy KM. 2010a. In vitro evaluation of the microbiota modulation abilities of different sized whole oat grain flakes. Anaerobe 16(5):483-8.
27. Connolly ML, Lovegrove JA, Tuohy KM. 2010b. Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. J Funct Foods 2(3):219-24.
28. Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Leonard C, Gibson GR, Tuohy KM. 2008. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br. J. Nutr. 99(1):110-20.
29. Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Amer J Physiol-Endocrinol Metab 292(3):E740-7.
30. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci 107(33):14691-6.
31. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol-Gastrointestinal Liver Physiol 299(2):G440-8.
32. Dessein R, Gironella M, Vignal C, Peyrin-Biroulet L, Sokol H, Secher T, Lacas-Gervais S, Gratadoux J, Lafont F, Dagorn J. 2009. Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis. Gut 58(6):771-6.
33. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 108(suppl 1):4554-61.
34. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6(11):e280.
35. Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Holle AV, Muccioli GG, Deldicque L, Bindels LB, Pachikian BD, Sohet FM. 2011. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem 22(8):712-22.
36. Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK. 2008. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2(7):716-27.
37. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci 107(26):11971-5.
38. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. 2007. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73(4):1073-8.
39. Duncan S, Lobley G, Holtrop G, Ince J, Johnstone A, Louis P, Flint H. 2008. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32(11):1720-4.
40. Eckel RH, York DA, Rössner S, Hubbard V, Caterson I, Jeor STS, Hayman LL, Mullis RM, Blair SN. 2004. Prevention conference VII obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation 110(18):2968-75.
41. EGGESBø M, Moen B, Peddada S, Baird D, Rugtveit J, Midtvedt T, Bushel PR, Sekelja M, Rudi K. 2011. Development of gut microbiota in infants not exposed to medical interventions. APMIS 119(1):17-35.
42. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60(11):2775-86.
43. Faith JJ, McNulty NP, Rey FE, Gordon JI. 2011. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 333(6038):101-4.
44. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. 2002. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 68(1):219-26.
45. Fei N, Zhao L. 2013. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J 7:880-84.
46. Finegold SM, Sutter VL, Mathisen G. 1983. Normal indigenous intestinal flora. Human intestinal microffora in health and disease. New York, N.Y.: Academic Press. p. 1-31.
47. Flöistrup H, Swartz J, Bergström A, Alm JS, Scheynius A, van Hage M, Waser M, Braun-Fahrländer C, Schram-Bijkerk D, Huber M. 2006. Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol 117(1):59-66.
48. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM, Murphy B, Ross RP, Fitzgerald GF, Stanton C. 2012. High-throughput sequencing reveals the incomplete, short-term, recovery of the infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamycin. Antimicrob Agents Chemotherapy 56(11):5811-20.
49. Friedman JM. 2009. Obesity: causes and control of excess body fat. Nature 459(7245):340-2.
50. Gill C, Rowland I. 2002. Diet and cancer: assessing the risk. Br J Nutr 88(S1):s73-87.
51. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, Gordon JI. 2011. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci 108(15):6252-7.
52. Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D, Ogra PL. 2004. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49(4):579-89.
53. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, Van Eden W, Versalovic J, Weinstock JV, Rook GA. 2006. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 3(5):275-84.
54. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. 2010. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103(1):58-68.
55. Hayashi H, Sakamoto M, Benno Y. 2002. Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol 46(12):819-31.
56. Hehemann J-H, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. 2010. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 464(7290):908-12.
57. Hemarajata P, Versalovic J. 2012. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 6(1):39-51.
58. Hess JR, Birkett AM, Thomas W, Slavin JL. 2011. Effects of short-chain fructooligosaccharides on satiety responses in healthy men and women. Appetite 56(1):128-34.
59. Hooper LV, Midtvedt T, Gordon JI. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22(1):283-307.
60. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485-98.
61. Kalliomäki M, Collado MC, Salminen S, Isolauri E. 2008. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87(3):534-8.
62. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. 2011. Human nutrition, the gut microbiome and the immune system. Nature 474(7351):327-36.
63. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov RI. 2008. Predominant role of host genetics in controlling the composition of gut microbiota. PLoS ONE 3(8):e3064.
64. Khandekar MJ, Cohen P, Spiegelman BM. 2011. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11(12):886-95.
65. Kleessen B, Schwarz S, Boehm A, Fuhrmann H, Richter A, Henle T, Krueger M. 2007. Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr 98(3):540-9.
66. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20(1):699-722.
67. Le Poul E, Loison C, Struyf S, Springael J-Y, Lannoy V, Decobecq M-E, Brezillon S, Dupriez V, Vassart G, Van Damme J. 2003. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278(28):25481-9.
68. Lee H-Y, Park J-H, Seok S-H, Baek M-W, Kim D-J, Lee K-E, Paek K-S, Lee Y, Park J-H. 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids 1761(7):736-44.
69. Ley RE. 2010. Obesity and the human microbiome. Curr Opin Gastroenterol 26(1):5-11.
70. Ley RE, Bä ckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070-5.
71. Ley RE, Peterson DA, Gordon JI. 2006a. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-48.
72. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006b. Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022-3.
73. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489(7415):220-30.
74. Maccarrone M, Gasperi V, Catani MV, Diep TA, Dainese E, Hansen HS, Avigliano L. 2010. The endocannabinoid system and its relevance for nutrition. Annu Rev Nutr 30:423-40.
75. MacFarlane GT, Macfarlane L. 2009. Acquisition, evolution and maintenance of the normal gut microbiota. Dig Dis 27(1):90-8.
76. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M, Kersten S. 2006. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281(2):934-44.
77. Mariat D, Firmesse O, Levenez F, Guimarǎes V, Sokol H, Dore J, Corthier G, Furet J. 2009. The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9(1):123, doi:10.1186/1471-2180-9-123.
78. Marques TM, Wall R, Ross RP, Fitzgerald GF, Ryan CA, Stanton C. 2010. Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 21(2):149-56.
79. Marra F, Lynd L, Coombes M, Richardson K, Legal M, FitzGerald JM, Marra CA. 2006. Does antibiotic exposure during infancy lead to development of asthma? A systematic review and metaanalysis. Chest J 129(3):610-8.
80. Martín R, Jiménez E, Heilig H, Fernández L, Marín ML, Zoetendal EG, Rodríguez JM. 2009. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75(4):965-9.
81. Martin CR, Walker WA. 2008. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 32(2):127-37.
82. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282-6.
83. McIntyre A, Gibson P, Young G. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34(3):386-91.
84. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G. 2011. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3(106):106ra.
85. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Macé K, Chou CJ. 2008. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22(7):2416-26.
86. Mikelsaar M, Stsepetova J, Hütt P, Kolk H, Sepp E, Lõivukene K, Zilmer K, Zilmer M. 2010. Intestinal Lactobacillus sp. is associated with some cellular and metabolic characteristics of blood in elderly people. Anaerobe 16(3):240-6.
87. Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, Valero R, Raccah D, Vialettes B, Raoult D. 2011. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes 36:817-25.
88. Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. 2012. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog 53(2):100-8.
89. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC. 2006. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72(2):1027-33.
90. Nam Y-D, Jung M-J, Roh SW, Kim M-S, Bae J-W. 2011. Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing. PLoS ONE 6(7):e22109.
91. O'Shea EF, Cotter PD, Stanton C, Ross RP, Hill C. 2012. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol 152(3):189-205.
92. O'Sullivan Ó, Coakley M, Lakshminarayanan B, Conde S, Claesson MJ, Cusack S, Fitzgerald AP, O'Toole PW, Stanton C, Ross RP. 2013. Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J Antimicrob Chemother 68(1):214-21.
93. O'Toole PW, Claesson MJ. 2010. Gut microbiota: changes throughout the lifespan from infancy to elderly. Intl Dairy J 20(4):281-91.
94. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336(6080):489-93.
95. Orrhage K, Nord C. 1999. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr 88:47-57.
96. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, Neulinger SC, Dauml; C, Heinsen F-A, Latorre A, Barbas C, Seifert J, Dos Santos VM, Ott SJ, Ferrer M, Moya A. 2013. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. In: Gut 62:1591-1601.
97. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. 2007. Development of the human infant intestinal microbiota. PLoS Biol 5(7):e177.
98. Parnell JA, Reimer RA. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Amer J Clin Nutr 89(6):1751-9.
99. Parnell JA, Reimer RA. 2012. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp rats. Br J Nutr 1(1):1-13.
100. Parracho H, McCartney AL, Gibson GR. 2007. Probiotics and prebiotics in infant nutrition. Proc Nutr Soc 66(3):405-11.
101. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2):511-21.
102. Pharmaceutiques UDL. 1995. Dietary modulation of the human colonie microbiota: introducing the concept of prebiotics. Pharmaceutiques 125:1301-1412.
103. Pyra KA, Saha DC, Reimer RA. 2012. Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats. J Nutr 142(2):213-20.
104. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59-65.
105. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. 2009. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101(04):541-50.
106. Ramnani P, Gaudier E, Bingham M, Van Bruggen P, Tuohy KM, Gibson GR. 2010. Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr 104:233-40.
107. Reinhardt C, Reigstad CS, Bäckhed F. 2009. Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 48(3):249-56.
108. Roberfroid M. 2007. Prebiotics: the concept revisited. J Nutr 137(3):830S-7S.
109. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watztl B, Szajewska H, Stahl B. 2010. Prebiotic effects: metabolic and health benefits. Br J Nutr 104(S2):S1-S63.
110. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. 2005. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Amer J Clin Nutr 82(3):559-67.
111. Samuel BS, Gordon JI. 2006. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci 103(26):10011-6.
112. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M. 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci 105(43):16767-72.
113. Sanders ME. 2008. Probiotics: considerations for human health. Nutr Rev 61(3):91-9.
114. Saulnier D, Spinler JK, Gibson GR, Versalovic J. 2009. Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 20(2):135-41.
115. Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M, Holmes E, Wang Y, Marchesi JR. 2008. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10(3):789-98.
116. Seki E, Brenner DA. 2008. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48(1):322-35.
117. Shen J, Obin MS, Zhao L. 2013. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 34(1):39-58.
118. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, Orandle M, Mayer L, Macpherson AJ, McCoy KD. 2011. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 17(12):1585-93.
119. Sommer F, Bäckhed F. 2013. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 11:227-38.
120. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN, Sonnenburg JL. 2010. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141(7):1241-52.
121. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. 2008. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14(3):166-71.
122. Steelman M, Weiss W, Maese F, Lechin M, Yanovski S, Yanovski J. 2002. Pharmacotherapy for obesity. N Engl J Med 346:2092-3.
123. Štšepetova J, Sepp E, Kolk H, Lõivukene K, Songisepp E, Mikelsaar M. 2011. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr 105(8):1235-44.
124. Tatum PM, Harmon CM, Lorenz RG, Dimmitt RA. 2010. Toll-like receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury. J Pediatr Surg 45(6):1246-55.
125. Ternak G. 2005. Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? Med Hypotheses 64(1):14-6.
126. Thomas CM, Versalovic J. 2010. Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1(3):148-63.
127. Thuny F, Richet H, Casalta J-P, Angelakis E, Habib G, Raoult D. 2010. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS ONE 5(2):e9074.
128. Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L, Rossmann P, Hrncir T, Kverka M, Zakostelska Z, Klimesova K, Pribylova J, Bartova J, Sanchez D, Fundova P, Borovska D, Srutkova D, Zidek Z, Schwarzer M, Drastich P, Funda DP. 2011. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 8(2):110-20.
129. Turnbaugh PJ, Gordon JI. 2009. The core gut microbiome, energy balance and obesity. J Physiol 587(17):4153-8.
130. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027-131.
131. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. 2009a. A core gut microbiome in obese and lean twins. Nature 457(7228):480-4.
132. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009b. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14.
133. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. 2009c. A core gut microbiome in obese and lean twins. Nature 457:480-4.
134. Tyakht AV, Kostryukova ES, Popenko AS, Belenikin MS, Pavlenko AV, Larin AK, Karpova IY, Selezneva OV, Semashko TA, Ospanova EA. 2013. Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun 4, doi: 10.1038/ncomms3469.
135. Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, Brigidi P. 2010. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 10(1):4, doi:10.1186/1471-2180-10-4.
136. Waldram A, Holmes E, Wang Y, Rantalainen M, Wilson ID, Tuohy KM, McCartney AL, Gibson GR, Nicholson JK. 2009. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 8(5):2361-75.
137. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A. 2010. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5(2):220-30.
138. Wall R, Ross R, Ryan C, Hussey S, Murphy B, Fitzgerald G, Stanton C. 2009. Role of gut microbiota in early infant development. Clin Med: Pediat 3:45-54.
139. Wang Z-T, Yao Y-M, Xiao G-X, Sheng Z-Y. 2004. Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J Gastroenterol 10(11):1619-24.
140. Wang Z, Xiao G, Yao Y, Guo S, Lu K, Sheng Z. 2006. The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma Acute Care Surg 61(3):650-7.
141. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y-M. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57-63.
142. Wells JM, Loonen LM, Karczewski JM. 2010. The role of innate signaling in the homeostasis of tolerance and immunity in the intestine. Int J Med Microbiol 300(1):41-8.
143. Willing BP, Russell SL, Finlay BB. 2011. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 9(4):233-43.
144. Wlodarska M, Willing B, Keeney K, Menendez A, Bergstrom K, Gill N, Russell S, Vallance B, Finlay B. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 79(4):1536-45.
145. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105-8.
146. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP. 2012. Human gut microbiome viewed across age and geography. Nature 486(7402):222-7.
147. Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G. 2010. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 16(27):3394-3401.
148. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499(7456):97-101.
149. Zimmer J, Lange B, Frick J-S, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P. 2011. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 66(1):53-60.